Literature DB >> 31911860

Pleiotropic role of macrophage migration inhibitory factor in cancer.

Maheedhara R Guda1, Matthew A Rashid1, Swapna Asuthkar1, Anvesh Jalasutram1, John L Caniglia1, Andrew J Tsung1,2,3, Kiran K Velpula1,2,4,5.   

Abstract

Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine that serves many roles in inflammation and immunity; however, it is also involved in carcinogenesis. This is a review of the clinical and experimental data published on MIF and its role in various types of cancers such as glioblastomas, lung cancer, breast cancer, gastric cancer, melanoma, bladder cancer, and head and neck cancers. The goal of this review is to show MIFs role in various types of cancers. Data show that MIF is overexpressed in these malignancies in humans, and contributes to the deregulation of the cell cycle, angiogenesis, and metastasis. Clinical studies show that MIF overexpression in these types of tumors significantly decreases survival rate, and increases tumor aggression. There are multiple anti-MIF molecules that are currently being explored and investigations should be continued. AJCR
Copyright © 2019.

Entities:  

Keywords:  CD74; MIF; cancer

Year:  2019        PMID: 31911860      PMCID: PMC6943360     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  66 in total

Review 1.  Links between mutant p53 and genomic instability.

Authors:  Walter Hanel; Ute M Moll
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

2.  Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF‑κB/HIF‑1α pathway in lung cancer.

Authors:  Jun Li; Junhua Zhang; Fengjiao Xie; Jiangzhou Peng; Xu Wu
Journal:  Int J Mol Med       Date:  2017-11-22       Impact factor: 4.101

3.  Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.

Authors:  Long-Jun He; Dan Xie; Pin-Jin Hu; Yi-Ji Liao; Hai-Xia Deng; Hsiang-Fu Kung; Sen-Lin Zhu
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

4.  Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.

Authors:  Suhendan Ekmekcioglu; Michael A Davies; Keiji Tanese; Jason Roszik; Myung Shin-Sim; Roland L Bassett; Denái R Milton; Scott E Woodman; Victor G Prieto; Jeffrey E Gershenwald; Donald L Morton; Dave S Hoon; Elizabeth A Grimm
Journal:  Clin Cancer Res       Date:  2016-01-18       Impact factor: 12.531

5.  CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.

Authors:  H Zhang; Y-L Ye; M-X Li; S-B Ye; W-R Huang; T-T Cai; J He; J-Y Peng; T-H Duan; J Cui; X-S Zhang; F-J Zhou; R-F Wang; J Li
Journal:  Oncogene       Date:  2016-10-10       Impact factor: 9.867

6.  Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor.

Authors:  H W Sun; J Bernhagen; R Bucala; E Lolis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

7.  Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.

Authors:  Nadège Kindt; Julie Preillon; Herbert Kaltner; Hans-Joachim Gabius; Dominique Chevalier; Alexandra Rodriguez; Bryon D Johnson; Véronique Megalizzi; Christine Decaestecker; Guy Laurent; Sven Saussez
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-25       Impact factor: 4.553

8.  Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.

Authors:  Eva Verjans; Erik Noetzel; Nuran Bektas; Anke K Schütz; Hongqi Lue; Birgitt Lennartz; Arndt Hartmann; Edgar Dahl; Jürgen Bernhagen
Journal:  BMC Cancer       Date:  2009-07-14       Impact factor: 4.430

9.  Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.

Authors:  John A Taylor; George A Kuchel; Poornima Hegde; Olga S Voznesensky; Kevin Claffey; John Tsimikas; Lin Leng; Richard Bucala; Carol Pilbeam
Journal:  BMC Cancer       Date:  2007-07-24       Impact factor: 4.430

Review 10.  Macrophage migration inhibitory factor involvement in breast cancer (Review).

Authors:  Vincent Richard; Nadège Kindt; Sven Saussez
Journal:  Int J Oncol       Date:  2015-09-24       Impact factor: 5.650

View more
  14 in total

1.  TPT1 Supports Proliferation of Neural Stem/Progenitor Cells and Brain Tumor Initiating Cells Regulated by Macrophage Migration Inhibitory Factor (MIF).

Authors:  Yukina Morimoto; Ayako Tokumitsu; Takefumi Sone; Yuki Hirota; Ryota Tamura; Ayuna Sakamoto; Kazunori Nakajima; Masahiro Toda; Yutaka Kawakami; Hideyuki Okano; Shigeki Ohta
Journal:  Neurochem Res       Date:  2022-05-27       Impact factor: 4.414

Review 2.  Polyploid giant cancer cell characterization: New frontiers in predicting response to chemotherapy in breast cancer.

Authors:  Geetanjali Saini; Shriya Joshi; Chakravarthy Garlapati; Hongxiao Li; Jun Kong; Jayashree Krishnamurthy; Michelle D Reid; Ritu Aneja
Journal:  Semin Cancer Biol       Date:  2021-03-22       Impact factor: 17.012

3.  7-Hydroxycoumarins Are Affinity-Based Fluorescent Probes for Competitive Binding Studies of Macrophage Migration Inhibitory Factor.

Authors:  Zhangping Xiao; Deng Chen; Shanshan Song; Ramon van der Vlag; Petra E van der Wouden; Ronald van Merkerk; Robbert H Cool; Anna K H Hirsch; Barbro N Melgert; Wim J Quax; Gerrit J Poelarends; Frank J Dekker
Journal:  J Med Chem       Date:  2020-10-13       Impact factor: 7.446

4.  MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma.

Authors:  Lifeng Qin; Jinmei Qin; Xiaoping Lv; Caiqiao Yin; Qian'e Zhang; Jiqiao Zhang
Journal:  Oncol Lett       Date:  2021-05-24       Impact factor: 2.967

5.  Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study.

Authors:  Martyna Parol-Kulczyk; Arkadiusz Gzil; Joanna Maciejewska; Magdalena Bodnar; Dariusz Grzanka
Journal:  PLoS One       Date:  2021-06-22       Impact factor: 3.240

Review 6.  Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair.

Authors:  Laura Farr; Swagata Ghosh; Shannon Moonah
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

7.  Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization.

Authors:  Francesco Petragnano; Ilaria Pietrantoni; Simona Camero; Silvia Codenotti; Luisa Milazzo; Francesca Vulcano; Giampiero Macioce; Ilenia Giordani; Paolo Tini; Sara Cheleschi; Giovanni Luca Gravina; Claudio Festuccia; Alessandra Rossetti; Simona Delle Monache; Alessandra Ordinelli; Carmela Ciccarelli; Annunziata Mauro; Barboni Barbara; Cristina Antinozzi; Amalia Schiavetti; Roberto Maggio; Luigi Di Luigi; Antonella Polimeni; Cinzia Marchese; Vincenzo Tombolini; Alessandro Fanzani; Nicola Bernabò; Francesca Megiorni; Francesco Marampon
Journal:  J Biomed Sci       Date:  2020-08-27       Impact factor: 8.410

Review 8.  Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?

Authors:  Eugenio Cavalli; Rosella Ciurleo; Maria Cristina Petralia; Paolo Fagone; Rita Bella; Katia Mangano; Ferdinando Nicoletti; Placido Bramanti; Maria Sofia Basile
Journal:  Molecules       Date:  2020-03-06       Impact factor: 4.411

9.  Prognostic role of macrophage migration inhibitory factor in patients with clear cell renal cell carcinoma.

Authors:  Hyo Jung An; Hyun Min Koh; Jong Sil Lee; Dae Hyun Song
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

10.  Characteristics of hypoxic tumor microenvironment in non-small cell lung cancer, involving molecular patterns and prognostic signature.

Authors:  Zhanghao Huang; Shuo Wang; Hai-Jian Zhang; You Lang Zhou; Xin Tang; Jia-Hai Shi
Journal:  Transl Lung Cancer Res       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.